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We have mapped the motor neurons (MNs) supplying the major hindlimb muscles of 
transgenic (C57/BL6J-ChAT-EGFP) and wild-type (C57/BL6J) mice. The fluorescent 
retrograde tracer Fluoro-Gold was injected into 19 hindlimb muscles. Consecutive transverse 
spinal cord sections were harvested, the MNs counted, and the MN columns reconstructed in 
3D. Three longitudinal MN columns were identified. The dorsolateral column extends from 
L4 to L6 and consists of MNs innervating the crural muscles and the foot. The ventrolateral 
column extends from L1 to L6 and accommodates MNs supplying the iliopsoas, gluteal, and 
quadriceps femoris muscles. The middle part of the ventral horn hosts the central MN 
column, which extends between L2–L6 and consists of MNs for the thigh adductor, 
hamstring, and quadratus femoris muscles. Within these longitudinal columns, the 
arrangement of the different MN groups reflects their somatotopic organization. MNs 
innervating muscles developing from the dorsal (e.g., quadriceps) and ventral muscle mass 
(e.g., hamstring) are situated in the lateral and medial part of the ventral gray, respectively. 
MN pools belonging to proximal muscles (e.g., quadratus femoris and iliopsoas) are situated 
ventral to those supplying more distal ones (e.g., plantar muscles). Finally, MNs innervating 
flexors (e.g., posterior crural muscles) are more medial than those belonging to extensors of 
the same joint (e.g., anterior crural muscles). These data extend and modify the MN maps in 
the recently published atlas of the mouse spinal cord and may help when assessing neuronal 
loss associated with MN diseases. 
Keywords: Hindlimb, spinal cord, motor neuron, retrograde tracing, musculotopic 
organization, 3D modeling 
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Introduction 
Motor neurons (MNs) form the final link between the motor cortex and skeletal muscles. We 
have mapped the topography and determined the number of MNs innervating limb muscles 
because we believe that these baseline data are important in a number of ways. Firstly, 
knowing the localization of the MN groups is vital for an understanding of the organization 
of this part of the motor system. Secondly, knowledge of the exact location of the MN groups 
is useful for designing and conducting electrophysiology experiments aimed at studying the 
motor supply of various muscles of the limbs. Thirdly, detailed information about the size 
and localization of the MN groups is important to the understanding of the pathogenesis, time 
course, symptoms, and nature of specific diseases targeting MNs, such as amyotrophic lateral 
sclerosis (ALS). Since in vivo labeling, mapping, and investigation in the human spinal cord 
is not technically possible, one must extrapolate from information available from the 
experimental animal studies. 
There are several established mouse models of ALS, which allow assessment of the 
MN loss accompanying the development of the disease. Hitherto, ALS research on animal 
models has focused on the superoxide dismutase 1 (SOD1) G93A ‘gain-of-function’ 
transgenic mouse strain (Gurney et al. 1994). SOD1
G93A
 mice demonstrate MN loss
resembling that seen in human ALS patients, but it is still not clear how the altered function 
of SOD1 results in MN loss (see e.g., Beckman et al. 1993; Wiedau-Pazos et al. 1996). 
Nevertheless, SOD1
G93A
 transgenic mice have been extensively used in ALS research
worldwide. In addition, new animal models have also become available, such as mouse 
strains having mutations at other points of SOD1, in ‘transactivating response element DNA 
binding protein-43’ (TDP-43), in Fused in Sarcoma/Translocated in Liposarcoma 
(FUS/TLS), or mice having diminished activity of the enzyme D-amino-acid oxidase (e.g., 
Kwiatkowski et al. 2009; Mackenzie et al. 2010; Joyce et al. 2011; Sasabe et al. 2012). 
Regardless of the nature of the mouse model, however, precise knowledge of the expected 
number of MNs belonging to the individual MN pools would be important for quantitative 
analysis of the MN loss associated with ALS and objective determination of the effectiveness 
of potential therapies. So far, in mouse models of ALS, damage to MNs has been assessed 
with a number of indirect measurements, including rotarod testing, footprint analysis, grip 
strength analysis, wire hang test, paw grip endurance, monitoring of body weight, and 
determination of the mass of selected muscles. Although these tests can provide valuable 
background information about some aspects of ALS, they are difficult to standardise. Some 
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studies have attempted to count MNs using histological sections of the spinal cord but these 
techniques suffer from a number of technical limitations. A problem facing all MN counting 
approaches is that not all MNs are affected at the same time — in SOD1
G93A
 mice, for 
example, lumbar MNs have been shown to deteriorate earlier than cervical ones (Azzouz et 
al. 2004). 
In our previous article we have reported on the distribution and size of MN pools 
innervating muscles of the forelimbs and shoulder girdle in C57BL/6J mice (Bácskai et al. 
2012). In the present work we extend our observations to MN pools of the lumbar spinal 
cord. The interpretation of spinal MN topography is complicated by a number of factors. 
Firstly, while some MN groups form distinct cluster, many have no clear borders and may 
overlap with MNs supplying a different muscle. Secondly, accidental spread of tracer to 
adjacent muscles may blur the pattern of MN topography. Thirdly, interstrain differences, 
including differences in the segmental distribution of some of the MN pools, may be a 
significant source of variation. For these reasons, we chose the retrograde tracer Fluoro-Gold 
(FG) and we reconstructed our results in 3D from a study of serial sections. We chose the 
C57BL mouse strain because of its importance in gene targeting experiments. We injected 
FG into 19 muscles of the hindlimb, mapped the location of the various MN groups, and we 
have counted the number of MNs innervating the individual muscles. The results of this study 
extend and modify the data presented in a recently published atlas of the mouse spinal cord 




Materials and Methods 
1. Animals 
Most experiments were carried out on B6.Cg-Tg(RP23-268L19-EGFP)2Mik/J transgenic 
mice, male and female, 8 weeks (21–25 g), n = 27, referred hereafter as ChAT-EGFP 
(choline acetyltransferase-enhanced green fluorescent protein), obtained from The Jackson 
Laboratory (Bar Harbour, ME, USA). In some cases, experiments were carried out on wild-
type C57/BL6 mice as well, 8–10 weeks (21–25 g, n = 10), obtained from the Animal 
Resources Centre (Canning Vale, WA, Australia). All experimental procedures were in 
accord with the Australian Code for the Care and Use of Animals in Research, and approved 
by the Animal Care and Ethics Committee of The University of New South Wales (ACEC 
No. 11/75A). 
2. Surgery and retrograde tracing  
The major steps of the MN labeling were the same as described in our recent article (Bácskai 
et al. 2012). In short, both ChAT-EGFP and wild-type mice were anesthetized with an 
intraperitoneal injection of ketamine (80 mg/kg) and xylazine (5 mg/kg). MNs were labeled 
with FG (Fluorochrome, Denver, CO, USA) diluted to 5% with distilled water. The FG 
solution was kept in dark, airtight containers in a refrigerator (4 °C) until used. All FG 
solution aliquots were used before their expiry date (6 months). Separate injections were 
made into the (1) gluteal muscle group (consisting of the gluteus superficialis and medius), 
(2) hamstring group (biceps femoris, semitendinosus, and semimembranosus), (3) adductor 
group (adductor magnus and longus, gracilis, and pectineus), (4) quadriceps group 
(quadriceps femoris), (5) ischiotrochanteric group (quadratus femoris), (6) iliacus group 
(iliopsoas), (7) posterior crural group (both superficial and deep muscles), (8) anterior crural 
group (both superficial and deep muscles), (9) lateral crural group (peroneus longus and 
brevis) and (10) foot. The muscles were exposed by incision and retraction of the skin under 
surgical microscope (Zeiss Stereomicroscope Stemi DV4; Zeiss, Oberkochen, Germany). To 
avoid inadvertent leakage of the tracer, the fascia of each injected muscle was left intact. In 
most mice, different muscles were labeled on the left and right side, since preliminary 
experiments confirmed that all connections were ipsilateral. Each muscle was injected in at 
least three mice. Identification of the targeted muscles was based on descriptions presented in 
Green (1959) and Hebel and Stromberg (1976), supplemented by our identification of 
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important anatomical landmarks (e.g., femoral artery, sciatic or femoral nerve), and the 
precise origin and insertion of each of the identified muscles. 
The FG solution was injected using a 5 μl Hamilton syringe (inner 
diameter = 0.33 mm; Hamilton Company, Reno, NV, USA). The tracer was injected slowly 
at multiple sites in each muscle, until the labeled muscle became distinctly colored, ensuring 
that the tracer filled its entire mass. Depending on the size of the muscle, the amount of FG 
applied was between 1.5 and 5 μl over a period of 2–5 minutes. In the cases of muscles with 
multiple heads, each head was injected separately or simultaneously. If leakage was noted 
during the tracer injection, the excess solution was immediately wiped away. After removing 
the needle from the muscle, the injection site was washed out with saline then covered by 
wax to minimize spread of FG to adjacent muscles. Examples of cases in which we judged 
the labeling to be complete, incomplete, or subject to excessive leakage of the FG into a 
neighboring muscle are shown in Fig 1. Following injections, the skin was sutured and 
tetracycline was sprayed over the incision. 
3. Tissue processing and localization of the motor neurons 
After a survival time of 6 days (Haenggeli and Kato 2002), mice were anesthetized with a 
lethal dose of pentobarbitone sodium (0.24 mg/g body weight) and transcardially perfused 
with 0.9% saline, followed by 4% paraformaldehyde prepared in 0.1 M phosphate buffer (pH 
7.4, 4 °C). 
After opening the vertebral canal and dura mater, spinal segments were carefully 
identified by dissecting the dorsal roots of the spinal nerves to their point of origin into the 
spinal cord. Because mice, even inbred mice, may have five, rather than six, lumbar vertebrae 
in some cases (McLaren and Michie 1954 and 1958), we examined the lumbar vertebral 
column after removal of the spinal cord to ensure that there were six lumbar vertebrae 
between the last rib and the sacrum. After removal of the spinal cord, a portion of each spinal 
cord containing segments T13–S1 was post-fixed overnight. For cryoprotection, the cords 
were placed in 30% sucrose buffer (4 °C, overnight). Serial transverse sections were cut 
using a Leica CM 1950 cryostat (Leica Microsystems GmbH, Wetzlar, Germany) at a 
thickness of 40 μm. Consecutive sections were collected, mounted, and coverslipped with 
Dako Fluorescence Mounting Medium (Dako, Campbellfield, Australia).  
Further identification of the individual spinal cord segments was based on the 




4. Cell counting and spinal cord reconstruction 
The sections were examined using a fluorescence microscope (BX51, Olympus, Tokyo, 
Japan) and photographed using an attached camera (AxioCam HRc, Zeiss). All sections 
containing labeled cells were mapped and the lumbar spinal cords were reconstructed in 3D 
using Neurolucida software (v10 with Zeiss Imager M2 microscope, MBF Bioscience Inc., 
Vermont, USA). All labeled MNs (including both α and γ motor neurons) having well-
defined nuclear area were counted on every second serial section using the ×20 objective of 
the fluorescence microscope. The total number of MNs innervating any particular muscle was 
determined by counting the number of labeled MN profiles along the entire length of the 
relevant spinal cord segments. To compensate for possible double counting of profiles, the 
actual cell numbers were corrected using the Abercrombie formula (Abercrombie 1946, 





1. General observations 
In native (i.e., non-labeled) spinal cord sections prepared from ChAT-EGFP mice, MNs 
could be identified on the basis of their ChAT positivity, which was evidenced by their strong 
green fluorescence (Fig. 2). As expected from our previous study of cervical spinal cord 
(Bácskai et al. 2012), the MNs formed relatively distinct cell clusters spread over 5 to 6 
spinal cord segments (in this case mostly from L1 to L6). By considering the rostrocaudal, 
dorsoventral, and mediolateral positions of the individual MN groups, we were able to 
identify specific hindlimb muscle groups. 
To ensure accurate classification of the MNs and to determine the number of cells 
innervating the individual muscles of the hindlimb, FG injections were always applied into 
individual muscles. FG-labeled cells could be easily identified on the basis of the strong 
fluorescence signal they emitted when visualized under the microscope. Generally, labeled 
MNs had their cell bodies and proximal processes filled with FG granules, whereas their 
nuclei remained unlabeled (Fig. 3). The majority of the MNs had large, polygonal cell bodies 
with a number of dendrites (Fig. 3a–b). About 10% of the labeled MNs had smaller and more 
spherical cell bodies, which generally had only two visible dendrites (Fig. 3c–e). The large 
and small MNs were classified as α-motor neurons and γ-motor neurons, respectively. 
2. Organization of the motor neurons supplying the hindlimb 
We injected 10 different groups of muscles with FG. In some cases all muscles associated 
with a muscle group were labeled (e.g., quadriceps femoris), while in other cases only the 
most easily accessible and/or biggest muscles were injected (e.g., ischiotrochanteric or iliacus 
group). Each muscle was labeled in at least three mice. While the number of MNs innervating 
the individual muscles was somewhat variable, their rostrocaudal extent was similar. The 
latter observation suggested that leakage of FG and inadvertent labeling of other MNs was 
minimal. 
In the subsequent sections, we give a detailed account of the distribution of the 
individual MN groups. An overview of all relevant data is provided in Table 1 and Table 2. 
The associated figures (Figs. 4–6) demonstrate the number and distribution of MNs 
innervating a representative muscle in each group. Our results relating to all other muscles 
are presented as supplementary material. The functions of the individual muscle groups are 
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consistent with the descriptions in Sherrington (1910), Crouch (1969), and Vanderhorst and 
Holstege (1997). 
2.1 Quadriceps group 
This group contains the quadriceps femoris and the sartorius muscles. However, because the 
mouse sartorius is only present up to the thirteenth day of the embryonic life (Lance Jones 
1979), our study concerned the MNs of the quadriceps femoris only. This muscle is mainly 
responsible for the extension of the knee. The four heads were injected simultaneously in 
each experiment. 
2.1.1. Quadriceps femoris 
The quadriceps MNs were arranged between L1 and L4, with the vast majority situated in L3. 
This MN column was the rostralmost of the hindlimb motor neuron groups in the lumbar 
cord. In transverse sections, the labeled cells occupied the ventromedial part of the ventral 
gray, ventral to the hamstring MN group. In rostral sections, the quadriceps MN group is 
located dorsomedial to the gluteal MN group, but more caudally it partially overlapped with 
that of the gluteal group (Fig. 4a1–a4). 
2.2 Iliacus group 
Muscles belonging to this group fix the vertebral column and flex the hip. Developmentally, 
the iliacus group consists of four muscles (psoas major, psoas minor, iliacus, and pectineus), 
but the pectineus is dealt with under heading 2.4.4. 
2.2.1. Iliopsoas 
The iliopsoas is formed by the psoas major and minor as well as the iliacus muscles. The 
caudal part of the iliopsoas was injected in three mice. Labeled MNs were localized in the 
most ventrolateral position of the ventral horn (Fig. 4b1–b4). Most FG-labeled cells were 
detected in L2–L3 but some were seen in L4, too. 
2.3. Gluteal muscle group 
According to their morphogenetic origin, the gluteal muscle group consists of seven muscles. 
(Lance Jones 1979). These muscles are responsible for the extension of the hip as well as for 
the abduction of the thigh. The two largest muscles belonging to this group (gluteus 
superficialis and gluteus medius) were injected in six mice. 
2.3.1. Gluteus superficialis 
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The gluteus superficialis was injected in two EGFP-ChAT mice and one wild-type mouse. 
The labeled MNs were situated in the ventrolateral part of the ventral horn. The vast majority 
of the labeled cells were found in L4 and L5 but some MNs were also identified in L3 and L6 
(Fig. 4c1–c4). 
2.3.2. Gluteus medius 
This muscle was injected in three mice. The rostrocaudal extent of the labeled neurons was 
similar to that of the gluteus superficialis MN group. FG-labeled cells were mostly detected 
in L4–L5 but some of them appeared in L3 and L6. MNs belonging to gluteus medius 
overlapped with those of the gluteus superficialis, forming a compact cell cluster within the 
boundaries of the gluteal MN group (see Online Resource 1). 
2.4. Adductor group  
Four muscles belonging to the adductor group were injected (namely, adductor magnus and 
longus, gracilis, and pectineus). Although the pectineus muscle belongs to the iliacus group 
on the basis of its morphogenetic origin (Lance Jones 1979), it is functionally more closely 
related to the adductor group. For this reason, we include the pectineus with the adductor 
group. The adductor MN group is located in the central cell column of the ventral horn. 
2.4.1. Adductor magnus 
The adductor magnus, the largest adductor, was injected in three mice. In two cases, the 
labeled MNs were detected from L2 to L5, inclusive. Within the boundaries of the adductor 
group, the cells belonging to the adductor magnus occupied the dorsomedial part but in more 
caudal segments they moved towards the ventral margin of the ventral horn (see Online 
Resource 2). 
2.4.2. Adductor longus 
Rostrocaudally, the extent of this MN group was almost the same as that of the adductor 
magnus MNs. The labeled MNs of adductor longus were detected between L2 and L5. In 
transverse sections, the labeled MNs were arranged in the medial part of the central cell 
column and overlapped with those of the adductor magnus (Fig. 5a1–a4). 
2.4.3. Gracilis 
In rodents, the gracilis possesses caudal and cranial heads. In the present experiments both 
heads were injected in each gracilis experiment (n = 3). The labeled cells extended from L3 
to L5. When the position of the most rostral part of the gracilis MN group was compared with 
those of the adductor magnus and longus, the gracilis MNs were located more caudally. In 
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transverse sections, the gracilis MNs were seen in the dorsal part of the main motor nucleus 
(see Online Resource 3). 
2.4.4. Pectineus 
The pectineus was injected in five mice. As expected, the MNs of this most proximal 
adductor were located in the most rostral spinal segment. Generally, the labeled cells were 
detected in L2–L3 and only a few cells were located in either L1 or L4. The labeled MNs 
were found in the central cell column of the ventral gray matter (see Online Resource 4). 
2.5. Hamstring group 
The hamstring group contains five muscles (Lance Jones 1979) and they are responsible for 
the flexion of the knee and, to a lesser extent, for extension of the hip. The hamstring MN 
group is localized in the central column, showing a notable shift towards the ventral part of 
the ventral horn in its most caudal portion. Moreover, as previously described, hamstring MN 
columns showed partial overlap with the gluteal MN groups (McHanwell and Biscoe 1981a). 
2.5.1. Biceps femoris 
The biceps femoris was injected in six mice. The biceps femoris consists of two heads and is 
innervated by two nerves. The inferior gluteal nerve innervates the anterior head, while the 
main hamstring nerve innervates the posterior head (McHanwell and Biscoe 1981a). For this 
reason, the two heads were injected separately. After the FG injection into the anterior head, 
labeled MNs appeared between L4 and L6. In the case of the posterior head, labeled MNs 
were present from a more caudal level (L5). In transverse sections, the biceps MNs were 
situated in the ventral part of the central MN column. MNs associated with the posterior head 
were located dorsomedially to those of the anterior head (see Online Resource 5). 
2.5.2. Semitendinosus 
The semitendinosus muscle was injected in three mice. The semitendinosus has two heads, 
which were injected together in each case. Labeled MNs were located between L3 and L6. 
The semitendinosus MN group occupied the medial part of the hamstring group, overlapping 
with the semimembranosus MNs (see Online Resource 6).  
2.5.3. Semimembranosus 
This muscle was injected in three mice. The semimembranosus has two heads in mice 
(medial and lateral heads) and both of them were injected together in each case. The 
rostrocaudal extent of the labeled MNs overlapped with that of the semitendinosus, and the 
cells distributed evenly along the whole length of this MN column. The semimembranosus 
12 
 
MNs belong to the central MN column of the ventral horn, situating dorsomedial to the MN 
group innervating the anterior head of the biceps (Fig 5b1–b4). 
2.6. Ischiotrochanteric group 
This group is formed by four small muscles, which are located between the ischial border and 
the trochanteric region. In the present study, only the largest and most easily accessible 
member of the group (i.e., quadratus femoris) was injected. The quadratus femoris is 
responsible for the lateral rotation of the hip. 
2.6.1. Quadratus femoris 
Quadratus femoris MNs were seen mostly between L4 and L6, but in two mice a few labeled 
cells were also detected in L3. As seen in transverse sections, rostrally the quadratus femoris 
MN group occupies the medial division of the central column. Caudally, the quadratus MNs 
shift laterally and overlap with those of the gluteal MN group (Fig 5c1–c4). 
2.7. Anterior crural group 
The anterior crural group contains the tibialis anterior (in the superficial layer), which rotates 
the ankle joint outward, whereas muscles belonging to the deep layer of the anterior crural 
group are responsible for the extension of the digits.  
2.7.1. Anterior crural superficial 
MNs of the tibialis anterior muscle are located in L4–L5 and belong to the dorsolateral cell 
column. The labeled cells were adjacent to the lateral border of the posterior crural group 
(Fig 6a1–a3). 
2.7.2. Anterior crural deep 
In transverse sections, this MN group had the same position as that of the anterior crural 
superficial muscles but they extended more caudally, as far as rostral L6 (see Online 
Resource 7). 
2.8. Lateral crural group 
The lateral muscle compartment of the leg contains the peroneus longus and brevis, which are 
responsible for the dorsiflexion of the foot. 
2.8.1. Peroneal muscles 
Both peroneal muscles were injected together in each of three mice. Labeled cells were seen 
in the dorsolateral column of L4–L5. Mediolaterally, this cell group was situating along the 
lateral border of the gray matter and overlapped with the anterior crural MNs (Fig 6b1–b3).  
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2.9. Posterior crural group 
Muscles belonging to this group are arranged in superficial and deep layers. All of them are 
flexors, acting on either the ankle or on the digits. 
2.9.1 Posterior crural superficial 
The superficial layer contains the triceps surae (consisting of the two heads of gastrocnemius, 
the soleus, as well as the plantaris muscle). The triceps surae is the main plantar flexor. All 
heads of the triceps surae were injected in every mouse (n = 3). The rostral part of the MN 
column was seen from L4, whereas its caudal end extended as far as L6. As Fig 6c1–c3 
demonstrates, the labeled cells were arranged in the medial part of the dorsolateral column. 
2.9.2. Posterior crural deep 
This layer contains the long flexors of the foot and the tibialis posterior. After injecting these 
deep muscles, labeled cells were detected between L4 and L6. In transverse sections, the 
relevant MNs were found in the dorsolateral cell column, medial to the extensor MNs (see 
Online Resource 8).  
2.10. Muscles of the foot 
The muscles of the foot act as flexors, extensors, adductors, and abductors of the digits. 
2.10.1. Extensor digitorum brevis 
Although the extensor digitorum brevis is located on the dorsal surface of the foot, it is not an 
‘intrinsic’ foot muscle. Rather, it belongs developmentally to the crural extensor muscle 
group. After injecting the extensor digitorum brevis, the majority of the FG-labeled MNs 
were seen in L6, although a few MNs were also detected in L5. MNs innervating the extensor 
digitorum brevis belong to the dorsolateral cell column (see Online Resource 9). 
2.10.2. Plantar muscles 
The majority of the labeled MNs appeared in L6 but some cells were detected in L5. In 





1. Methodological considerations relating to retrograde tracing 
MNs are essential but vulnerable parts of the motor system. Damage to these neurons has a 
huge impact on quality of life. It should not be surprising, therefore, that investigation of the 
distribution of MNs innervating individual limb muscles has attracted much attention in the 
past. Precise knowledge regarding the topography of MNs has clinical relevance, especially 
with the advent of animal models resembling human ALS. 
The pioneering studies of Waldeyer (1888), Kaiser (1891), and Romanes (1941, 1951, 
1964) revealed the basic principles of organization of spinal MNs. However, as Routal and 
Pal (1999) pointed out about a century later, unless retrograde tracing is applied, defining the 
territories of the MN groups is very difficult. Most importantly, the individual MN groups 
have imperfect boundaries. Furthermore, the size and shape of these clusters are highly 
variable, resulting in marked differences which are not only present when closely related 
species are considered (e.g., rats and mice) but they are evident within the same species or 
even when the two sides of the same spinal section are compared. Early studies without the 
benefit of modern retrograde tracing methods were handicapped in their efforts to define the 
relationships between muscle groups and motor neuron clusters (Romanes, 1951). 
When horseradish peroxidase (HRP) retrograde labeling became a standard technique, 
most of these difficulties could be effectively dealt with, yielding some very careful and 
detailed mapping of mammalian hindlimb MN groups (McHanwell and Biscoe 1981a,b; 
Nicolopoulos-Stournaras and Iles 1983, Vanderhorst and Holstege 1997). These studies are 
benchmarks in the field of MN labeling, so that one might reasonably ask whether additional 
studies regarding hindlimb MN groups are justified. The comprehensive nature of these 
studies may be one reason why relatively few articles have been published on this subject in 
recent times. Recent articles are mostly focused on a limited number of muscles, often in 
association with ALS (e.g., Mohajeri et al. 1998). 
Nevertheless, thematic studies aimed at mapping and quantification of MN groups 
innervating forelimb and hindlimb muscles are still timely and important. Most importantly, 
very little information is available on mice of the C57BL/6J strain, which is the strain on 
which most transgenic lines are based. Interspecies comparisons are limited in value and 
variability exists even within the same strain (Rigaud et al., 2008). Ideally, researchers should 
have access to detailed data from the relevant strain to have a comprehensive understanding 
of the actual size and distribution of the various MN groups. This is especially true for the 
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quantitative data, which have specific relevance when characterizing the progression of MN 
loss and efficacy of treatment strategies in animal models of ALS. 
In the present work, we chose FG as a retrograde tracer because it offers some clear 
advantages (Schmued and Fallon 1986; Mohajeri et al. 1998). FG is not degraded by 
lysosomes, thus it provides strong labeling that remains visible for a long period of time (up 
to one year). FG injection does not affect the function of the labeled muscles. Additionally, 
FG is a fluorescent dye and can therefore be visualized using conventional fluorescence or 
confocal microscopy. These techniques permit acquisition of high quality images and also 
allow the application of advanced image processing, including 3D reconstruction. Although 
this approach has been already successfully utilized by Yan et al. (2007) for the description of 
the spatial distribution of MNs innervating the rat trapezius muscle, the method has not 
hitherto been extended to muscle groups innervating an entire limb. Although there have been 
reports indicating that FG may have detrimental effects on the labeled neurons (e.g., Garrett 
et al. 1991; Franklin and Druhan 2000; Naumann et al. 2000), other studies did not observe 
neurotoxic effects associated with FG application (e.g., Emsley et al. 2001; McClellan et al. 
2006). Because the situation is not yet clear, the possibility of adverse effect must be borne in 
mind when using FG tracing. 
Despite well-regarded earlier attempts to map and characterize MN groups 
innervating individual muscles of the mammalian hindlimb, we believe that our study is 
particularly relevant for a number of reasons. Firstly, the present study was conducted on 
mice belonging to the C57BL strain, whereas the study of McHanwell and Biscoe (1981a) 
was conducted on C129ReJ mice; our results can therefore be directly applied to describe the 
MN loss in transgenic ALS models based on the C57BL strain. Secondly, the green 
fluorescence of the MNs allowed easy and reliable comparison of the positions of the FG-
labeled (yellow) and non-labeled (green) MN groups in the same spinal section. Thirdly, the 
application of FG allowed reliable and easily detectable labeling of the individual MN 
groups. Fourthly, FG is less prone to spreading, thus inadvertent labeling of non-innervating 
MNs was less likely than with the application of HRP. Finally, for the first time in the 
literature, we have developed a 3D model to provide a better understanding of the spatial 
distribution of the labeled hindlimb MN groups. 
2. A difference between C57BL and C129ReJ mice 
When comparing our results on C57BL mice with those of McHanwell and Biscoe (1981a) 
on C129ReJ mice, we noticed an important difference in the segmental level supplying the 
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intrinsic muscles of the foot. In the C57BL mice these MNs were located in the L6 segment, 
whereas in C129ReJ mice they were identified by McHanwell and Biscoe (1981a) as lying in 
the L5 segment. This interesting strain difference indicates that the hindlimb enlargement of 
the cord in the C129ReJ mouse is prefixed by one segment compared to the C57BL mouse. 
Interstrain differences such as this have been previously reported and occasionally such 
variation occurs among members of the same strain (Rigaud et al., 2008). 
3. Motoneuron columns in the ventral horn 
Since the careful study of Romanes (1951), it has been known that limb MNs form three 
distinct longitudinal columns in the ventral horn. Although the rostrocaudal extent of these 
columns shows interspecies variability (see Table 3 for details), their relative positions are 
consistent in studies of rat, mouse, and cat (McHanwell and Biscoe 1981a,b; Nicolopoulos-
Stournaras and Iles 1983, Vanderhorst and Holstege 1997). In our work, we also identified 
these cell columns (Fig. 7). 
Ventrolateral (VL) cell column: The VL cell column appears in the rostralmost 
position of the ventrolateral part of the lumbar gray matter. At the level of L1, the VL column 
begins with MNs innervating the quadriceps femoris. Inside the cell column, the quadriceps 
MNs occupy the dorsomedial part and remain in this position as far as L4. At the level of L2, 
the iliopsoas MNs form the most lateral part of the VL column. More caudally (L3), the 
gluteal MNs join this column, situating between the iliopsoas and quadriceps MNs, and 
ventral to the quadriceps group. 
Dorsolateral (DL) cell column: The DL column extends from L4 to L6 and 
accommodates MNs innervating the muscles of the crural region and the intrinsic 
musculature of the foot. The most lateral part of this column is occupied by MNs belonging 
to the lateral crural muscles, whereas the ventromedial part of the DL column is formed by 
MNs of the anterior crural muscles. These two muscle groups are innervated by branches of 
the common peroneal nerve. In our study, the lateral crural MN group (related to muscles 
supplied by the superficial peroneal nerve) terminated more rostrally (L5), whereas the 
anterior crural MN group could be followed as far as L6. In previous studies on mice and 
rats, the lateral crural MNs were reported to extend somewhat more caudally (e.g., 
McHanwell and Biscoe 1981a, Nicolopoulos-Stournas and Iles 1983). The explanation for 
this difference is not certain, although the possible variability of the actual extent of the 
individual MN groups, as well as differences in the applied techniques may contribute to the 
different observations. The medial part of the DL cell column is formed by MNs innervating 
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the posterior crural muscles, while the dorsal-most area of the DL cell column contains MNs 
supplying the intrinsic musculature of the foot. 
Central cell column: The central cell column is located in the middle of the ventral 
horn, extending from L2 to L6. Its rostral part is formed by MNs of the adductor muscles. 
Rostrally, this MN column is seen in a dorsolateral position, but it shifts medially and 
ventrally as it approaches more caudal spinal segments (e.g., L5). At the level of L3, some 
hamstring MNs (i.e., those supplying the semimembranosus and semitendinosus) join the 
medial part of the adductor MN column. More caudally, the hamstring MN group, along with 
the entire central cell column, shifts towards a more ventromedial position and terminates in 
L6. The third MN group of the central column innervates the quadratus femoris, which is a 
member of the ischiotrochanteric group. The relevant MNs appear in L3 and occupy the most 
ventral and medial position of the central group. The quadratus femoris cell group extends to 
L6 and shifts dorsomedially within the central MN column. 
4. Somatotopic organization of the MNs in the ventral horn 
The MNs groups are arranged to form longitudinal cell columns and they show a conserved 
organization when viewed in transverse sections of the spinal cord. This arrangement of the 
individual MN groups is related to the ontogenetic origin, localization, and function of the 
innervated muscles (Lance Jones 1979; Ryan et al. 1998). 
First, as it has been noted previously (Lance Jones 1979), the muscles of the lower 
limb can be grouped on the basis of their ontogenetic origin. MNs pools innervating these 
groups are arranged mediolaterally in the ventral horn. MNs belonging to muscles that 
develop from the dorsal muscle mass (e.g., quadriceps femoris and gluteal muscles) are 
situated in the lateral part of the ventral gray. In contrast, MNs innervating muscles 
originating from the ventral muscle mass (e.g., adductors, hamstring, and ischiotrochanteric 
muscles) occupy the medial part of the ventral horn. 
Second, MN pools also show a dorsoventral distribution, based on the position of the 
supported muscle relative to the pelvis; MNs supplying proximal muscles are present more 
ventrally. In our study, MNs innervating muscles of the hip joint (e.g., iliopsoas, gluteal, and 
quadratus femoris) occupied the ventralmost position, whereas MNs of the dorsalmost cell 
group supplied the most distal muscles of the hindlimb — the intrinsic musculature of the 
foot. The MNs that innervate muscles of the knee (i.e., adductors, hamstring, and quadriceps) 
and the ankle joints (i.e., anterior, lateral, and posterior crural muscles) were situated between 
those of the hip and the foot. It should be noted that the localization of the muscles did not 
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only correlate with the dorsoventral positions of the MNs but with their rostrocaudal 
arrangement as well. The rostrocaudal position of each MN group also reflects the proximo-
distal localization of the innervated muscles. For example, MNs innervating the iliopsoas (the 
most proximally located muscle in our experiments) were located between L2 and L4, 
whereas MNs belonging to the more distal quadratus femoris appeared in L3–L6 segments. 
Similarly, MNs of the more proximal lateral crural muscle were seen more rostrally (L4–L5) 
than those of the most distally located plantar muscles (L5–L6). 
Third, MNs are also arranged according to the function of the muscles they innervate. 
Similar to the situation noted in the upper limb (Bácskai et al. 2012), the clusters of flexor 
and extensor MNs showed a mediolateral orientation. MNs belonging to the posterior crural 
muscles, the main flexors of the ankle joint, were situated more medially than those of the 
anterior crural muscles (i.e., the extensors of the ankle). MNs innervating the flexors (i.e., 
hamstring muscles) and the extensors (i.e., quadriceps femoris) of the knee joint show a 
similar pattern of organization. 
5. The iliopsoas problem 
There have been only a few attempts to localize the MN groups associated with the iliopsoas 
and the results are difficult to interpret. In their study on rats, Nicolopoulos-Stournas and Iles 
(1983) labeled the iliacus motor neurons only. They found the iliacus MN column to lie in the 
middle part of the ventral horn, adjacent to the white matter, and medial to that of the 
pectineus. Vanderhorst and Holstege (1997) injected the entire distal part of the cat iliopsoas 
with retrograde tracer and the labeled motor neurons were in two distinct groups: one was in 
the ventrolateral corner of the ventral horn, and another in the medial part of the ventral horn, 
near the white matter. Selective targeting of the psoas revealed the ventrolateral MN group 
only. The mouse spinal cord atlas (Watson et al. 2009a) represents the psoas MN group in the 
medial part of the ventral horn, close to the position of the putative iliacus MN column in the 
cat (Vanderhorst and Holstege, 1997). In our present work, after injecting the distal part of 
the iliopsoas, only one MN group was seen, which was situated in the ventrolateral corner of 
the ventral horn (Fig. 4b1–b4). This position is identical to that associated with the position 
of the psoas MNs in the cat (Vanderhorst and Holstege, 1997). 
Additionally, the iliopsoas MN group does not appear to obey some of the 
organization rules explained previously. It is known that MNs innervating muscles 
developing from the ventral and dorsal muscle masses are preferentially localized to the 
medial and lateral parts of the ventral gray, respectively. However, as the iliopsoas develops 
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from both muscle masses (Lance Jones 1979), this rule of organization is not applicable. 
Moreover, iliopsoas MNs seem to breach the rule governing the relative positions of flexors 
and extensors. The iliopsoas muscle is a major flexor of the hip, thus its MNs would be 
expected more medial than those of the hip extensors (i.e., the gluteal group). However, in 
two most relevant studies (Nicolopoulos-Stournas and Iles 1983; Vanderhorst and Holstege 
1997), and in the present one, the gluteal and iliopsoas MN groups appear to occupy very 
similar positions. 
6. Relevance of the present findings to ALS research 
The present results are relevant to ALS research. ALS is one of the most devastating 
neurological diseases (e.g., Boillée et al. 2006), progressing rapidly and affecting both motor 
neurons (Hanyu et al. 1982) and long spinal tracts (Sobue et al. 1987). In the past years, over 
500 products and several treatment strategies have been investigated (e.g. Miller et al. 2005; 
Nagano et al. 2005a,b; Ralph et al. 2005; Chi et al. 2006; de Hemptinne et al. 2006; Traynor 
et al. 2006; Orrell, 2010) with rather limited success even in the most promising cases (e.g., 
Bensimon et al. 1994; Azzouz et al. 2004; Bachurin et al. 2011, or Cudkowicz et al. 2011). It 
is clear that objective assessment of efforts aimed at finding suitable ALS therapies would be 
assisted by extensive testing on suitable animal models, thorough scrutiny of the results with 
methods that permit monitoring of the progression of the disease, and quantitative analysis of 
the neuronal loss associated with ALS. It has been suggested that methodological problems 
associated with preclinical trials performed on mouse models might be behind the lack of 
translation of therapies from animal models to patients (Joyce et al. 2011). It follows that 
there is a strong need to have objective and easily quantifiable data that would assist ALS 
research. The data presented in this study and in our study of forelimb muscles (Bácskai et 
al., 2012), along with those demonstrated in some earlier efforts (e.g., McHanwell and Biscoe 
1981a,b; Watson et al. 1982; Ashwell and Watson 1983; Watson et al. 2009a,b; McHanwell 
and Watson 2009) are useful in this regard for a number of reasons. 
First, establishing and comparing the number of MNs innervating individual muscles 
in control and SOD1
G93A
 mice may provide information about the onset, progression, and 
severity of the MN loss. 
Secondly, it has been noted that in the earliest phase of ALS, the motor neuron 
terminals are withdrawn from the innervated skeletal muscle fibers resulting in the 
discontinuation of the motor neuron-skeletal muscle contact (Kong and Xu 1998; Frey et al. 
2000; Fischer et al. 2004; Pun et al. 2006). Since this phase is not accompanied by neural 
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degeneration or clinical symptoms, the only way to identify this stage is to recognize the 
reduction of the number of available neuromuscular junctions. Because labeling of the motor 
neurons after intramuscular injection of the retrograde tracer requires intact neuromuscular 
junctions, this method can give indication of the onset and early progression of the disease, 
even in the absence of clinical symptoms or without signs of muscular atrophy. However, to 
detect reduction of the labeled motor neuron numbers in animal models of ALS, age-matched 
canonical values are needed — such as those provided by our present and preceding work 
(Bácskai et al. 2012). 
Thirdly, it would be useful to gain detailed information about the distribution of 
muscle groups that are more prone to motor neuron loss in ALS. MNs innervating fast-
fatigable skeletal muscle fibers are more prone to neuronal damage associated with ALS than 
fast–fatigue-resistant (showing intermediate susceptibility), or slow fibers (Frey et al., 2000; 
Pun et al, 2006). It follows that muscles containing high proportion of slow fibers (e.g., 
soleus) are expected to be affected less severely than those having a higher proportion of fast-
fatigable fibers (e.g., biceps). However, these trends cannot be confirmed unless reliable 
information is available about the number of MNs innervating the relevant muscles in control 
mice. 
Finally, although functional studies are important for assessing the onset, course, and 
severity of ALS as well as for determining the effects of new treatment strategies, these 
studies are often difficult to quantify and compare objectively. Our present results provide 
objective data to describe the number of MNs in control mice, which could assist research 
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Demonstration of the results of good and technically inappropriate iliopsoas injections. (a) 
Image taken after muscle injection when the tracer did not fill the muscle completely. Only 
few, faintly labeled motor neurons are visible. (b) Result of a good muscle injection. The 
labeled motor neurons appear in the expected territory of the iliopas motor nucleus, forming a 
tight cluster of cells. (c) Extensive leakage of FG. Labeled motor neurons are not confined to 
the expected territory of the iliopsas motor nucleus but they are present in adjacent regions, 
including the putative motor nucleus of the quadriceps muscle. Labelings exemplified in (a) 
(c) were not taken into consideration during the analysis but the relevant experiments were 
repeated. Each image was taken from different mice at the level of L3. Scale bar: 200 µm. 
Figure 2 
ChAT-EGFP expression from L1 to L6. The cholinergic MNs are visible as green profiles in 
the ventral horn. The putative borders of the individual MN groups are also indicated. MN 
groups indicated by asterisk could not be unambiguously associated with any muscle or 
muscle group. Scale bar: 200 µm. 
Figure 3 
High magnification images demonstrating FG-labeled MNs in the lumbar spinal cord. (a–b) 
Putative α-motor neurons. (c–d) Putative γ-motor neurons. Scale bar: 20 µm. 
Figure 4 
Extent and organization of MN groups innervating the quadriceps femoris, iliopsoas, and 
gluteus superficialis muscles. (a1–a3) Photomicrographs of transverse sections from different 
levels of the spinal cord (as indicated in the bottom-right corner) after FG injections into the 
quadriceps femoris. The inset in (a2) depicts the topography of the MN columns as 
demarcated in transverse sections prepared from a ChAT-EGFP mouse. The MN group with 
the framed abbreviation corresponds to that revealed by retrograde labeling. (a4) 3D 
reconstruction of the number and distribution of MNs innervating the quadriceps femoris. 
Gray lines mark the border of the gray matter, green circles represent the central canal, and 
each red dot corresponds to the cell body of a single MN. White (rostralmost), blue, and 
yellow (caudalmost) arrows indicate the positions where the photomicrographs were taken. 
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(b1–b4) Number and distribution of MNs innervating the iliopsoas. The organization of the 
panels is the same as in (a1–a4). (c1–c4) Number and distribution of MNs innervating the 
gluteus superficialis. The organization of the panels is the same as in (a1–a4). D: dorsal, C: 
caudal, L: lateral, and M: medial. Scale bars: 200 µm. 
Figure 5 
Extent and organization of MN groups innervating the adductor longus, semimembranosus, 
and quadratus femoris. (a1–a4) Number and distribution of MNs innervating the adductor 
longus. (b1–b4) Number and distribution of MNs innervating the semimembranosus. (c1–c4) 
Number and distribution of MNs innervating the quadratus femoris. The organization of the 
panels is the same as in Figure 3. D: dorsal, C: caudal, L: lateral, and M: medial. Scale bars: 
200 µm. 
Figure 6 
Extent and organization of MN groups innervating the anterior crural superficial, lateral 
crural, posterior crural superficial, and plantar foot muscles. (a1–a3) Number and distribution 
of MNs innervating the anterior crural superficial muscles. (b1–b3) Number and distribution 
of MNs innervating the lateral crural muscles. (c1–c3) Number and distribution of MNs 
innervating the posterior crural superficial muscles. (d1–d3) Number and distribution of MNs 
innervating the plantar foot muscles. The organization of the panels is the same as in 
Figure 3. D: dorsal, C: caudal, L: lateral, and M: medial. Scale bars: 200 µm. 
Figure 7 
A synopsis of the data demonstrating the rostrocaudal extents and organization of MN 
columns innervating the major muscles of the mouse hindlimb. The borders of the individual 
spinal cord segments are indicated. Gray columns with black borders demonstrate the extent 
of MN groups as presented in the mouse spinal cord atlas (Watson et al. 2009a). In the case 




Legends to the supplementary material 
Online Resource 1 
Extent and organization of the MN group innervating the gluteus medius. (a1–a3) 
Photomicrographs of transverse sections from different levels of the spinal cord (as indicated 
in the bottom-right corner) after FG injections. (a4) 3D reconstruction of the number and 
distribution of MNs innervating the gluteus medius. Gray lines mark the border of the gray 
matter, green circles represent the central canal, and each red dot corresponds to the cell body 
of a single MN. White (rostralmost), blue, and yellow (caudalmost) arrows indicate the 
positions where the photomicrographs were taken. D: dorsal, C: caudal, and L: lateral. Scale 
bar: 200 µm. 
Online Resource 2 
Extent and organization of the MN group innervating the adductor magnus. (a1–a3) 
Photomicrographs of transverse sections from different levels of the spinal cord (as indicated 
in the bottom-right corner) after FG injections. (a4) 3D reconstruction of the number and 
distribution of MNs innervating the adductor magnus. Gray lines mark the border of the gray 
matter, green circles represent the central canal, and each red dot corresponds to the cell body 
of a single MN. White (rostralmost), blue, and yellow (caudalmost) arrows indicate the 
positions where the photomicrographs were taken. D: dorsal, C: caudal, and M: medial. Scale 
bar: 200 µm. 
Online Resource 3 
Extent and organization of the MN group innervating the gracilis. (a1–a3) Photomicrographs 
of transverse sections from different levels of the spinal cord (as indicated in the bottom-right 
corner) after FG injections. (a4) 3D reconstruction of the number and distribution of MNs 
innervating the gracilis. Gray lines mark the border of the gray matter, green circles represent 
the central canal, and each red dot corresponds to the cell body of a single MN. White 
(rostralmost), blue, and yellow (caudalmost) arrows indicate the positions where the 
photomicrographs were taken. D: dorsal, C: caudal, and M: medial. Scale bar: 200 µm. 
Online Resource 4 
Extent and organization of the MN group innervating the pectineus. (a1–a2) 
Photomicrographs of transverse sections from different levels of the spinal cord (as indicated 
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in the bottom-right corner) after FG injections. (a3) 3D reconstruction of the number and 
distribution of MNs innervating the pectineus. Gray lines mark the border of the gray matter, 
green circles represent the central canal, and each red dot corresponds to the cell body of a 
single MN. White (rostral) and yellow (caudal) arrows indicate the positions where the 
photomicrographs were taken. D: dorsal, C: caudal, and M: medial. Scale bar: 200 µm. 
Online Resource 5 
Extent and organization of MN groups innervating the biceps femoris. (a1–a3) 
Photomicrographs of transverse sections from different levels of the spinal cord (as indicated 
in the bottom-right corner) after FG injections into the anterior head of biceps femoris 
muscle. (b1–b2) Photomicrographs of transverse sections from different levels of the spinal 
cord (as indicated in the bottom-right corner) after FG injections into the posterior head of 
biceps femoris. (c1–c2) 3D reconstruction of the number and distribution of MNs innervating 
the anterior and posterior heads. Gray lines mark the border of the gray matter, green circles 
represent the central canal, and each red dot corresponds to the cell body of a single MN. 
White (rostralmost), blue, and yellow (caudalmost) arrows indicate the positions where the 
photomicrographs were taken. D: dorsal, C: caudal, and M: medial. Scale bars: 200 µm. 
Online Resource 6 
Extent and organization of the MN group innervating the semitendinosus. (a1–a3) 
Photomicrographs of transverse sections from different levels of the spinal cord (as indicated 
in the bottom-right corner) after FG injections. (a4) 3D reconstruction of the number and 
distribution of MNs innervating the semitendinosus. Gray lines mark the border of the gray 
matter, green circles represent the central canal, and each red dot corresponds to the cell body 
of a single MN. White (rostralmost), blue, and yellow (caudalmost) arrows indicate the 
positions where the photomicrographs were taken. D: dorsal, C: caudal, and M: medial. Scale 
bar: 200 µm. 
Online Resource 7 
Extent and organization of the MN group innervating the deep anterior crural muscles. (a1–
a3) Photomicrographs of transverse sections from different levels of the spinal cord (as 
indicated in the bottom-right corner) after FG injections. (a4) 3D reconstruction of the 
number and distribution of MNs innervating the deep anterior crural muscles. Gray lines 
mark the border of the gray matter, green circles represent the central canal, and each red dot 
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corresponds to the cell body of a single MN. White (rostralmost), blue, and yellow 
(caudalmost) arrows indicate the positions where the photomicrographs were taken. D: 
dorsal, C: caudal, and L: lateral. Scale bar: 200 µm. 
Online Resource 8 
Extent and organization of the MN group innervating the deep posterior crural muscles. (a1–
a3) Photomicrographs of transverse sections from different levels of the spinal cord (as 
indicated in the bottom-right corner) after FG injections. (a4) 3D reconstruction of the 
number and distribution of MNs innervating the deep posterior crural muscles. Gray lines 
mark the border of the gray matter, green circles represent the central canal, and each red dot 
corresponds to the cell body of a single MN. White (rostralmost), blue, and yellow 
(caudalmost) arrows indicate the positions where the photomicrographs were taken. D: 
dorsal, C: caudal, and L: lateral. Scale bar: 200 µm. 
Online Resource 9 
Extent and organization of the MN group innervating the extensor digitorum brevis. (a1–a2) 
Photomicrographs of transverse sections from different levels of the spinal cord (as indicated 
in the bottom-right corner) after FG injections. (a3) 3D reconstruction of the number and 
distribution of MNs innervating the extensor digitorum brevis. Gray lines mark the border of 
the gray matter, green circles represent the central canal, and each red dot corresponds to the 
cell body of a single MN. White (rostral) and yellow (caudal) arrows indicate the positions 






Ad9   adductor MNs of lamina 9 
ALS   amyotrophic lateral sclerosis 
Ant   anterior 
Ax9   axial MNs of lamina 9 
BAC   Bacterial Artificial Chromosome  
CC   central canal 
ChAT   choline acetyltransferase 
CEx9   crural extensor MNs of lamina 9 
CFl9   crural flexor MNs of lamina 9 
Cr9   cremaster MNs of lamina 9 
CV   Coefficient of variation 
Dig   digitorum 
DL   dorsolateral 
EGFP   enhanced green fluorescent protein 
ExA9   external anal sphincter MNs of lamina 9 
Ext   extensor 
ExU9   external urethral sphincter MNs of lamina 9 
FG   Fluoro-Gold 
FUS/TLS  Fused in Sarcoma/Translocated in Liposarcoma 
Gl9   gluteal MNs of lamina 9 
Hm9   hamstring MNs of lamina 9 
HRP   horseradish peroxidase 
IML   intermediolateral nucleus 
Lat   Lateral 
LDCom  lumbar dorsal commissural nucleus 
MN   motor neuron 
Pes9   foot MNs of lamina 9 
Post   posterior 
Q9   quadriceps MNs of lamina 9 
QL9   quadratus lumborum MNs of lamina 9 
SDCom  sacral dorsal commissural nucleus 
SOD1   superoxide dismutase 1 
Spf   superficial 
TDP-43  Transactivating response element DNA binding protein-43 
VL   ventrolateral 
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Table 1 
Number and distribution of FG-labeled MNs innervating the major muscles of the mouse hindlimb 




Total number of FG-labeled neurons in 












L1 L2 L3 L4 L5 L6  Mean ± S.E.M (aCV)  
Biceps femoris — 
anterior head 




M4 87 – – – – 73 14 72  
  
M41 80 – – – 29 26 25 61  
Biceps femoris — 
posterior head 
M16 61 – – – – 46 15 48 26 ± 11 (0.74) 
  
M35 17 – – – – 10 7 13  
  
M36 22 – – – – 3 19 17  
Gluteus superficialis M3 67 – – – 13 52 2 54 72 ± 9 (0.22) 
146 (109–184) 
  
M4 96 – – 3 36 57 – 77  
  
M20 106 – – 48 19 27 12 85  
Gluteus medius M5 38 – – 10 8 20 – 31 45 ± 11 (0.43) 
  
M6 82 – – 2 36 37 7 67  
  
M21 48 – – – 18 15 15 37  
Semimembranosus M7 105 – – 28 21 32 24 83 84 ± 2 (0.05) 58 (55–61) 
  
M8 114 – – 11 60 30 13 88   
  
M9 103 – – 1 18 33 51 80   




M8 111 – – 26 57 23 5 83   
  
M9 73 – – – 6 24 43 58   
Table 1
Gracilis M10 67 – – 38 21 8 – 54 42 ± 6 (0.24) 35 (27–39) 
  
M11 49 – – 27 19 3 – 39   
  
M12 43 – – 21 8 14 – 34   
Quadriceps M11 126 13 19 88 6 – – 102 88 ± 15 (0.33) 172 (140–209) 
  
M12 159 13 11 100 35 – – 123   
  
M21 84 9 3 53 19 – – 67   
  
M22 81 – 5 67 9 – – 61   
Adductor magnus M13 33 – – 8 15 10 – 27 66 ± 21 (0.54) 
150 (130–171) 
  
M14 94 – 2 9 22 61 – 74  
  
M24 121 – 20 64 8 29 – 98  
Adductor longus M16 45 – 8 25 2 10 – 36 47 ± 16 (0.58) 
  
M17 36 – 3 17 13 3 – 27  
  
M25 103 – 7 95 1 – – 78  
Pectineus M13 32 – 8 24 – – – 26 73 ± 19 (0.59) 20 (13–27) 
  
M14 117 3 20 91 3 – – 95   
  
M15 34 – 14 20 – – – 28   
  
M24 150 – 17 126 7 – – 117   
  
M37 135 – 34 90 11 – – 102   
Posterior crural 
superficial 
M19 71 – – – – 59 12 57 83 ± 25 (0.52) 
251 (208–308) 
  
M25 174 – – – 12 58 104 133  
  
M26 79 – – – 14 61 4 60  
Posterior crural deep M19 144 – – – 12 123 9 115 144 ± 16 (0.19) 
  
M29 232 – – – 18 105 109 170  
  
M30 190 – – – 15 127 48 147  
Quadratus femoris M18 53 – – – 38 11 4 42 58 ± 8 (0.25) 42 (39–44) 
  
M28 (left) 87 – – 6 35 35 11 68   
  
M28 (right) 83 – – 1 33 34 15 65   
Iliopsoas M27 (left) 28 – 4 24 – – – 22 28 ± 4 (0.25) 
No data 
  
M27 (right) 32 – 2 20 10 – – 26  
  
M41 47 – 12 35 – – – 36  
Plantar muscles M31 (left) 123 – – – – 18 105 90 98 ± 4 (0.08) 190 (167–219) 
  
M31 (right) 137 – – – – 14 123 105   
  
M35 125 – – – – 3 122 99   
Extensor digitorum 
brevis 




M33 30 – – – – 2 28 24   
  
M38 40 – – – – 2 38 30   
Lateral crural M29 66 – – – 10 56 – 52 82 ± 15 (0.32) 
188 (185–195) 
  
M30 124 – – – 6 118 – 97  
  
M38 132 – – – 38 86 8 97  
Anterior crural deep M33 68 – – – 12 54 2 54 74 ± 22 (0.51) 
  
M34 63 – – – 21 39 3 50  
  
M39 158 – – – 37 111 10 118  
Anterior crural 
superficial 
M32 52 – – – 26 26 – 40 62 ± 12 (0.33) 
  
M34 103 – – – 59 44 – 81  
  
M39 86 – – – 42 44 – 65  
a
CV: Coefficient of variation (calculated as standard deviation over mean). 
b
McHanwell S, Biscoe TJ (1981) The localization of motor neurons supplying the hindlimb muscles of the mouse. Philos Trans R Soc Lond B Biol 
Sci 293:477–508. Horseradish peroxidase tracer, 48 hrs survival. Mean (minimum–maximum). 
c
The motor neuron numbers were reported after 24 hrs survival 
Table 2 
Size of the cell nuclei of FG-labeled MNs innervating the major muscles of the mouse hindlimb 
Injected muscle Mouse ID 
a
Average 
diameter of cell 
nuclei (µm) 
Mean ± S.E.M. 
 
Biceps femoris — ant. head M3 9.3 ± 0.5 
  
M4 8.7 ± 0.4 
  
M41 12.1 ± 0.6 
Biceps femoris — post. head M16 10.5 ± 0.4 
  
M35 12.6 ± 0.5 
  
M36 11.4 ± 0.6 
Gluteus superficialis M3 9.2 ± 0.4 
  
M4 9.9 ± 0.3 
  
M20 9.8 ± 0.4 
Gluteus medius M5 9.1 ± 0.4 
  
M6 9.0 ± 0.2 
  
M21 11.7 ± 0.6 
Semimembranosus M7 10.4 ± 0.4 
  
M8 11.8 ± 0.6 
  
M9 11.5 ± 0.5 
Semitendinosus M7 11.7 ± 0.4 
 
M8 13.5 ± 0.4 
  
M9 10.5 ± 0.3 
Gracilis M10 10.1 ± 0.5 
  
M11 10.9 ± 0.3 
  
M12 10.1 ± 0.3 
Quadriceps M11 9.4 ± 0.4 
  
M12 11.9 ± 0.7 
  
M21 10.0 ± 0.7 
  
M22 13.3 ± 0.6 
Adductor magnus M13 9.0 ± 0.5 
  
M14 10.6 ± 0.4 
  
M24 9.4 ± 0.8 
Pectineus M13 9.9 ± 0.5 
Table 2
  
M14 9.5 ± 0.2 
  
M15 8.7 ± 0.3 
  
M24 11.4 ± 0.6 
  
M37 12.7 ± 0.6 
Adductor longus M16 10.6 ± 0.4 
  
M17 12.6 ± 0.7 
  
M25 13.0 ± 0.9 
Posterior crural superficial M19 9.9 ± 0.3 
  
M25 12.5 ± 0.5 
  
M26 13.1 ± 0.4 
Posterior crural deep M19 10.1 ± 0.5 
  
M29 14.5 ± 0.5 
  
M30 11.8 ± 0.5 
Quadratus femoris M18 10.8 ± 0.6 
  
M28 (left) 11.5 ± 0.5 
  
M28 (right) 10.7 ± 0.4 
Iliopsoas M27 (left) 10.4 ± 0.3 
  
M27 (right) 9.1 ± 0.6 
  
M41 12.5 ± 0.4 
Lateral crural M29 10.8 ± 0.5 
  
M30 11.1 ± 0.3 
  
M38 14.3 ± 0.5 
Plantar muscles M31 (left) 14.5 ± 0.7 
  
M31 (right) 12.2 ± 0.8 
  
M35 10.5 ± 0.7 
Extensor digitorum brevis M32 10.6 ± 0.3 
  
M33 11.0 ± 0.5 
  
M38 13.0 ± 0.7 
Anterior crural deep M33 10.0 ± 0.4 
  
M34 10.0 ± 0.3 
  
M39 13.7 ± 0.6 
Anterior crural superficial M32 11.5 ± 0.7 
  
M34 11.0 ± 0.5 
  
M39 13.1 ± 0.7 
a
The mean diameter of the cell nuclei was determined on the basis of ten randomly chosen nuclei in each 
motor neuron pool. 
Table 3 
Rostrocaudal distribution of motor neuron columns innervating the major muscles of the hindlimb 
Name of the muscle 
Rostrocaudal position and extent of the relevant motor neuron column 
MOUSE 














L3–L6 L4–L6 L3–L4 L3 L6–S1 N/A 
L5 L6–L7 L5–S2 
Gluteus mediusA L3–L6 L4–L6 L3–L4 L3 L6–S1 N/A 
Biceps femoris — 
anterior headB 
L4–L6 L4–L6 L3–L4 L3–L5 L7–S1 L7–S1 
L5 L6–L7 L5–S1 
Biceps femoris — 
posterior headB 
L5–L6 L4–L6 L3–L4 L3–L5 L7–S1 S1–S2 
SemimembranosusB L3–L6 L4–L6 L2–L4 L3–L5 L6–L7 L6–L7 
SemitendinosusB L3–L6 L4–L6 L2–L4 L3–L5 L6–L7 L7–S1 
GracilisC L3–L5 L2–L3 L2–L3 L1–L3 L5–L7 N/A 
L3–L4 L4–L5 L3–L4 
Adductor magnusC L2–L5 L2–L3 L1–L3 L1–L3 L5–L7 N/A 
Adductor longusC L2–L5 L2–L3 L1–L3 L1–L3 L5–L6 N/A 
PectineusC *L2-L4 L2–L3 L1–L2 L1–L3 L5–L6 N/A 
Quadriceps 
femorisD 
L1–L4 L2–L3 L1–L3 L2–L3 L5–L6 L6–L7 L3–L4 L4–L5 L3–L4 
Quadratus femorisE L3–L6 N/A L3–L5 N/A N/A N/A N/A N/A N/A 
IliopsoasF L2–L4 
#
L2–L3 N/A L1–L2 N/A N/A L3–L4 L4–L5 L3–L4 
Posterior crural 
superficialG 
L4–L6 L4–L5 L2–L4 L3–L4 L7–S1 L7–S2 
L5–L6 L6–L7 L5 
Posterior crural 
deepG 




L4–L5 L4–L5 L3–L4 L3–L4 L6–S1 N/A 
L4–L6 L6–L7 L5 Anterior crural 
superficialH 
L4–L5 L4–L5 L3–L4 L3–L4 L6–S1 L6–S1 
Anterior crural 
deepH 
L4–L6 L4–L5 L3–L4 L3–L4 L6–S1 L7–S1 
Extensor digitorum 
brevisH 
L5–L6 L6 L3 N/A N/A N/A 
PlantarI L5–L6 L6 L3–L5 L4–L5 L7–S1 N/A L6 S1 S1–S2 




Watson et al. 2009a; 
c
McHanwell and Biscoe 1981; 
d
Nicolopoulos-Stournaras and Iles 1983; 
e
Vanderhorst and Holstege 1997; 
f
Portal et al. 1990; 
g
Sengul et al. 2012. 
+
Assumed positions. These data are not the results of specific labeling experiments but they are based on cluster morphology. 
++
The results were obtained by intramuscular injection of HRP or by its application to the cut end of the nerve supplying the relevant muscle. 
A
Gluteal group (Gl9); 
B
Hamstring group (Hm9); 
C
Adductor group (Add9); 
D
Quadriceps femoris (Q9); 
E





Crural flexor group (CFl9); 
H
Crural extensor group (CEx9); 
I
Intrinsic musculature of the foot (Pes9). 
*
In one mouse (M14) three motor neurons were observed in L1. We think this may be the result of inadvertent spread of the tracer. 
**
In one mouse (M38) 6% of the labeled motor neurons (8/132) appeared in L6. We think this may be the result of spreading or individual 
variability. 
#
In the atlas, only the position of the psoas motor neuron group is indicated. However, the depicted position appears correspond to that of the 
iliacus motor neuron group on the basis of the present study. 
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